What does Xencor Inc (XNCR) do?

Xencor Inc (XNCR) is a publicly traded company in the Healthcare sector.

What sector does XNCR operate in?

Xencor Inc operates in the Healthcare, specifically within the Biotechnology industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find XNCR earnings analysis?

AlphaOS publishes an earnings intelligence page for Xencor Inc (XNCR) covering results, guidance context, and AI-assisted analysis. See /stocks/XNCR/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

XNCR

Xencor Inc

Healthcare · Biotechnology

$25.00Sep 29, 2026

AI confidence 71% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Xencor Inc shows stable business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +17% YoY in Q2 FY2026.

TrajectoryStable

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue +17% YoY in Q2 FY2026

Pipeline evidence · 0d ago

XNCR's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on XNCR.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full XNCR earnings analysis

Reported figures for Xencor Inc — research only, not investment advice.

Revenue YoY: +17.5%

Latest Intelligence

Updated September 30, 2026

What happened recently for Xencor Inc (XNCR) — events, not interpretation.

Event: Reported Q2 2026 revenue +18% YoY.
Also: Last session September 29, 2026 at $25.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Xencor Inc (XNCR)

Healthcare · Biotechnology

Investment Snapshot above is the primary AlphaOS analysis for Xencor Inc — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Biotechnology
Market cap:: $1.86B
Revenue:: $51.22M

XNCR earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Xencor Inc through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Themes

Genomics & Biotech

Genomics & Biotech beneficiaries

Related & Connected

Connected companies and research pages from the AlphaOS knowledge graph.